FDA Gene Therapy Office Chief Prefers Flexibility With Accelerated Approval Confirmatory Trials

 
• By Derrick Gingery
  
Nicole Verdun at 2023 ASGCT Policy Summit
Nicole Verdun (left) discussed accelerated approval and other cell and gene therapy issues during the ASGCT Policy Summit. • Source: Screenshot of conference livestream

More from Cell & Gene Therapies

More from Advanced Technologies